Selective serotonin reuptake inhibitors (SSRI) and osteoporosis;Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) et ostéoporose

Revue Medicale Suisse

Volumn 7, Issue 299, 2011, Pages 1299-1304

  Fetique Will A C ^a   Chevalley, T ^b   Rizzoli, R ^b  

^a HUG   (Switzerland)

^b HUG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

BONE DENSITY; BONE METABOLISM; DEPRESSION; FALL RISK; FRACTURE; HEALTH PRACTITIONER; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PROSPECTIVE STUDY; SHORT SURVEY; SIDE EFFECT; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EVIDENCE BASED MEDICINE; RISK FACTOR;

BONE DENSITY; DEPRESSION; EVIDENCE-BASED MEDICINE; HUMANS; OSTEOPOROSIS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 80051709000     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Bolton JM, Metge C, Lix L, et al. Fracture risk from psychotropic medications : A population-based analysis. J Clin Psychopharmacol 2008;28:384-91.
2. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007;167:188-94. (Pubitemid 46148067)
3. Calarge CA, Zimmerman B, Xie D, Kuperman S, Schlechte JA. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. J Clin Psychiatry 2010;71:338-47.
4. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007; 167:1246-51. (Pubitemid 46998495)
5. Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women : The study of osteoporotic fractures. Arch Intern Med 2007;167:1240-5. (Pubitemid 46998494)
6. Williams LJ, Henry MJ, Berk M, et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 2008;23:84-7. (Pubitemid 351317280)
7. Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH. Bone mineral density in subjects using central nervous system-active medications. Am J Med 2005;118:1414.
8. Spangler L, Scholes D, Brunner RL, et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 2008;23:567-74.
9. Lewis CE, Ewing SK, Taylor BC, et al. Predictors of non-spine fracture in elderly men : The MrOS study. J Bone Miner Res 2007;22:211-9. (Pubitemid 46167791)
10. French DD, Campbell R, Spehar A, Cunningham F, Foulis P. Outpatient medications and hip fractures in the US : A national veterans study. Drugs Aging 2005; 22:877-85. (Pubitemid 41539949)
11. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 2006;17:807-16. (Pubitemid 43781493)
12. Vestergaard P, Rejnmark L, Mosekilde L. Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 2008;82:92-101.
13. Ziere G, Dieleman JP, van der Cammen TJ, et al. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 2008;28:411-7.
14. Abrahamsen B, Brixen K. Mapping the prescriptiome to fractures in men - a national analysis of prescription history and fracture risk. Osteoporos Int 2009; 20:585-97.
15. van den Brand MW, Pouwels S, Samson MM, et al. Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 2009;20:1705-13.
16. Verdel BM, Souverein PC, Egberts TC, et al. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 2010;47:604-9.